Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma

Ovarian clear cell carcinoma (OCCC) is a subtype of epithelial ovarian cancer (EOC) that is associated with elevated interleukin-6 (IL-6) expression, resistance to chemotherapy, and increased mortality. Although bevacizumab (Bev) is a widely used anti-angiogenic agent for EOC, the efficacy of Bev an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Seki, Toshiyuki, Yanaihara, Nozomu, Shapiro, Jason Solomon, Saito, Misato, Tabata, Junya, Yokomizo, Ryo, Noguchi, Daito, Kuroda, Takafumi, Kawabata, Ayako, Suzuki, Jiro, Takahashi, Kazuaki, Matsuzawa, Haruka, Miyake, Misayo, Takenaka, Masataka, Iida, Yasushi, Yanagida, Satoshi, Okamoto, Aikou
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032732/
https://ncbi.nlm.nih.gov/pubmed/33833265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86913-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados